At iQue® (formerly Intellicyt), our mission is to enable bioscience enterprises to rapidly and cost effectively screen and profile disease- and physiologically-relevant model systems for phenotypic endpoints using cell-based and/or bead-based assays. We do this by providing easy-to-use hardware, software, and reagent systems that are optimized to conserve precious samples, use less reagent, and to minimize time-to-answer to both enhance workflow productivity and to preserve the biology of interest. All major pharmaceutical companies and many biotechnology companies and academic institutions have invested in iQue® Advanced Flow Cytometry Platform solutions, to give their cell-based screening campaigns the edge.
Looking for a particular iQue® Advanced Flow Cytometry Platform employee's phone or email?
The iQue® Advanced Flow Cytometry Platform annual revenue was $3.5 billion in 2026.
1 people are employed at iQue® Advanced Flow Cytometry Platform.
iQue® Advanced Flow Cytometry Platform is based in Albuquerque, New Mexico.
The NAICS codes for iQue® Advanced Flow Cytometry Platform are [33, 334, 62, 621, 3345, 33451].
The SIC codes for iQue® Advanced Flow Cytometry Platform are [38, 382].